Detalles de la búsqueda
1.
COMPANION-002 A clinical trial of investigational drug CTX-009 plus paclitaxel vs paclitaxel in second line advanced BTC.
Future Oncol
; : 1-8, 2024 Jun 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38861293
2.
Open-label, Phase 2 study of roxadustat for the treatment of anemia in patients receiving chemotherapy for non-myeloid malignancies.
Am J Hematol
; 98(5): 703-711, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36710399
3.
A Phase 2 Study of PCI-27483, a Factor VIIa Inhibitor in Combination with Gemcitabine for Advanced Pancreatic Cancer.
Oncology
; 96(4): 217-222, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30844808
4.
APF530 (granisetron injection extended-release) in a three-drug regimen for delayed CINV in highly emetogenic chemotherapy.
Future Oncol
; 12(12): 1469-81, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26997579
5.
An open-label, single-arm, phase 2 (PX-171-004) study of single-agent carfilzomib in bortezomib-naive patients with relapsed and/or refractory multiple myeloma.
Blood
; 119(24): 5661-70, 2012 Jun 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-22555973
6.
Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial.
Lancet Oncol
; 14(4): 335-45, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23499390
7.
Oral decitabine-cedazuridine versus intravenous decitabine for myelodysplastic syndromes and chronic myelomonocytic leukaemia (ASCERTAIN): a registrational, randomised, crossover, pharmacokinetics, phase 3 study.
Lancet Haematol
; 11(1): e15-e26, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38135371
8.
A Phase Ib/II Study of Pepinemab in Combination with Avelumab in Advanced Non-Small Cell Lung Cancer.
Clin Cancer Res
; 27(13): 3630-3640, 2021 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33820783
9.
Real-world effectiveness of palonosetron-based antiemetic regimens: preventing chemotherapy-induced nausea and vomiting.
J Comp Eff Res
; 8(9): 657-670, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31070042
10.
A Phase I Dose-Escalation Study of Veliparib Combined with Carboplatin and Etoposide in Patients with Extensive-Stage Small Cell Lung Cancer and Other Solid Tumors.
Clin Cancer Res
; 25(2): 496-505, 2019 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30327308
11.
Real-world efficacy: intravenous palonosetron three-drug regimen for chemotherapy-induced nausea and vomiting with highly emetogenic chemotherapy.
J Comp Eff Res
; 7(12): 1161-1170, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30304955
12.
Phase I/II study of mocetinostat in combination with gemcitabine for patients with advanced pancreatic cancer and other advanced solid tumors.
Cancer Chemother Pharmacol
; 81(2): 355-364, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29238851
13.
Voxtalisib (XL765) in patients with relapsed or refractory non-Hodgkin lymphoma or chronic lymphocytic leukaemia: an open-label, phase 2 trial.
Lancet Haematol
; 5(4): e170-e180, 2018 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-29550382
14.
Inhibition of the Nuclear Export Receptor XPO1 as a Therapeutic Target for Platinum-Resistant Ovarian Cancer.
Clin Cancer Res
; 23(6): 1552-1563, 2017 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27649553
15.
A multicenter, randomized trial of long-acting octreotide for the optimum prevention of chemotherapy-induced diarrhea: results of the STOP trial.
J Support Oncol
; 4(6): 289-94, 2006 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-16805331
16.
A randomized Phase II trial of the tumor vascular disrupting agent CA4P (fosbretabulin tromethamine) with carboplatin, paclitaxel, and bevacizumab in advanced nonsquamous non-small-cell lung cancer.
Onco Targets Ther
; 9: 7275-7283, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27942221
17.
First-in-Class, First-in-Human Phase I Study of Selinexor, a Selective Inhibitor of Nuclear Export, in Patients With Advanced Solid Tumors.
J Clin Oncol
; 34(34): 4142-4150, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-26926685
18.
Establishing the dosage equivalency of oxymorphone extended release and oxycodone controlled release in patients with cancer pain: a randomized controlled study.
Curr Med Res Opin
; 20(6): 911-8, 2004 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-15200750
19.
A phase I study in patients with solid or hematologic malignancies of the dose proportionality of subcutaneous Azacitidine and its pharmacokinetics in patients with severe renal impairment.
Pharmacotherapy
; 34(5): 440-51, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24877181
20.
PRECEDENT: a randomized phase II trial comparing vintafolide (EC145) and pegylated liposomal doxorubicin (PLD) in combination versus PLD alone in patients with platinum-resistant ovarian cancer.
J Clin Oncol
; 31(35): 4400-6, 2013 Dec 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-24127448